Dipartimento di Medicina Molecolare e Traslazionale
A cura di: PIZZI Marina SPANO Pier Franco Sfoglia la rubrica The present invention relates to a pharmaceutical composition comprising at least one histone deacetylase inhibitor, and at least one sirtuin activator agent having the general formula described. Such composition is used as a medication to treat chronic neurodegenerative diseases, and/or in the treatment of tumours […]
Composizione farmaceutica il suo uso Leggi tutto »
A cura di: POLA Annalisa POLI Maura Sfoglia la rubrica The invention relates to a new medical application of sulphated glycosaminoglycans, particularly heparin, low molecular weight heparin and derivatives thereof, in the therapeutic treatment of anaemia, in particular iron deficiency anaemia, chronic disease anaemia (also known as inflammatory anaemia) and iron-refractory iron-deficient anaemia (IRIDA). The mechanism
A cura di: ANTONINI ANGELO LANZILLOTTA ANNAMARIA PIZZI Marina SPANO Pier Franco Sfoglia la rubrica The present invention relates to an in vitro method of diagnosing a neurological disease associated with at least one symptom selected from the group comprising non-motor symptoms, sleep-wake disorders, sensory disorders, neuropsychiatric disorders and cognitive difficulties, comprising measuring the amount of active c-Rel
Procedimento diagnostico in vitro della malattia di Parkinson Leggi tutto »
A cura di: TIRA Maurizio Sfoglia la rubrica Partner dell’attivita’: Dipartimento: ATE, DIGI, DEM, DICATAM, DIMI, DII, DMMT, DSCS, DSMC Anni di svolgimento: 2013 – Presente Record ID: 26 Chi ha visto questo articolo può essere interessato a:Io non me l’aspettavoXV Convegno – Obiettivi di Sviluppo Sostenibile e Ambiente: Ruolo delle tecnologie appropriate nella…Al via
